| JYHB2500228 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs | Supplementary Application | 2025-04-19 | | The Wellcome Foundation Ltd;Delpharm Poznan SA | | | view |
| JYHB2400623 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs | Supplementary Application | 2024-11-30 | | The Wellcome Foundation Ltd;Delpharm Poznan SA | | | view |
| JYHB2400624 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs | Supplementary Application | 2024-11-30 | | The Wellcome Foundation Ltd;Delpharm Poznan SA | | | view |
| JYHB2400622 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs | Supplementary Application | 2024-11-30 | | The Wellcome Foundation Ltd;Delpharm Poznan SA | | | view |
| JYHB2400625 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs | Supplementary Application | 2024-11-30 | | The Wellcome Foundation Ltd;Delpharm Poznan SA | | | view |
| JYHB2400621 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs | Supplementary Application | 2024-11-30 | | The Wellcome Foundation Ltd;Delpharm Poznan SA | | | view |
| CYHS2401546 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs(4) | Generic Drug | 2024-05-23 | | Hebei Renhe Yikang Pharmaceutical Co Ltd;Renhe Yikang Group Co Ltd | | | view |
| CYHB2400029 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs(4) | Supplementary Application | 2024-01-04 | | Xi'an Yuanda Detian Pharmaceutical Co Ltd | | | view |
| CYHS2301773 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs(4) | Generic Drug | 2023-07-01 | | Jiangxi Shimei Pharmaceutical Co Ltd | | | view |
| CYHS2301772 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs(4) | Generic Drug | 2023-07-01 | | Jiangxi Shimei Pharmaceutical Co Ltd | | | view |
| JYHZ2200147 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs(5.1) | License Renew | 2022-06-17 | | GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA | | | view |
| JYHZ2200150 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs(5.1) | License Renew | 2022-06-17 | | GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA | | | view |
| JYHZ2200151 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs | License Renew | 2022-06-17 | | GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA | | | view |
| JYHZ2200149 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs(5.1) | License Renew | 2022-06-17 | | GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA | | | view |
| JYHZ2200148 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs(5.1) | License Renew | 2022-06-17 | | GlaxoSmithKline (China) Investment Co Ltd;The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA | | | view |
| CYHS2200782 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs(4) | Generic Drug | 2022-05-27 | | Anhui Pioneer Pharmaceutical Co Ltd | | | view |
| CYHS2200781 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs(4) | Generic Drug | 2022-05-27 | | Anhui Pioneer Pharmaceutical Co Ltd | | | view |
| JYHB2101194 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2021-06-21 | | The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA | | | view |
| JYHB2101192 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2021-06-21 | | The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA | | | view |
| JYHB2101193 | 拉莫三嗪分散片 | lamotrigine | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2021-06-21 | | The Wellcome Foundation Ltd;GlaxoSmithKline Phaemaceuticals SA | | | view |
